166 related articles for article (PubMed ID: 495513)
1. Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure.
Rubin SA; Chatterjee K; Ports TA; Gelberg HJ; Brundage BH; Parmley WW
Am J Cardiol; 1979 Nov; 44(6):1183-9. PubMed ID: 495513
[TBL] [Abstract][Full Text] [Related]
2. Hydralazine therapy in severe chronic heart failure: inability of radionuclide left ventricular ejection fraction measurement to predict the hemodynamic response.
Goldberg MJ; Franklin BA; Rubenfire M; Kerin NZ; Willens HJ; Ruskin R
J Am Coll Cardiol; 1983 Nov; 2(5):887-93. PubMed ID: 6313788
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute and chronic minoxidil administration on rest and exercise hemodynamics and clinical status in patients with severe, chronic heart failure.
Nathan M; Rubin SA; Siemienczuk D; Swan HJ
Am J Cardiol; 1982 Nov; 50(5):960-6. PubMed ID: 7137047
[TBL] [Abstract][Full Text] [Related]
4. Rest and exercise hemodynamic effects of oral hydralazine in patients with coronary artery disease and left ventricular dysfunction.
Hindman MC; Slosky DA; Peter RH; Newman GE; Jones RH; Wallace AG
Circulation; 1980 Apr; 61(4):751-8. PubMed ID: 7357717
[TBL] [Abstract][Full Text] [Related]
5. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA
Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031
[TBL] [Abstract][Full Text] [Related]
6. Vasodilators as first-line therapy for congestive heart failure: a comparative hemodynamic study of hydralazine, digoxin, and their combination.
Ribner HS; Zucker MJ; Stasior C; Talentowski D; Stadnicki R; Lesch M
Am Heart J; 1987 Jul; 114(1 Pt 1):91-6. PubMed ID: 3604877
[TBL] [Abstract][Full Text] [Related]
7. Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects.
Chatterjee K; Ports TA; Brundage BH; Massie B; Holly AN; Parmley WW
Ann Intern Med; 1980 May; 92(5):600-4. PubMed ID: 7386999
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral hydralazine on rest and exercise hemodynamics in patients with aortic or mitral regurgitation and left ventricular dysfunction.
Slosky DA; Hindman MC; Peter RH; Wallace AG
Clin Cardiol; 1981; 4(4):162-7. PubMed ID: 7273499
[TBL] [Abstract][Full Text] [Related]
9. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.
Massie BM; Kramer B; Shen E; Haughom F
Br Heart J; 1981 Apr; 45(4):376-84. PubMed ID: 7225252
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
[TBL] [Abstract][Full Text] [Related]
11. MDL 17,043: short- and long-term cardiopulmonary and clinical effects in patients with heart failure.
Rubin SA; Tabak L
J Am Coll Cardiol; 1985 Jun; 5(6):1422-7. PubMed ID: 3158690
[TBL] [Abstract][Full Text] [Related]
12. Circulatory improvement after hydralazine or isosorbide dinitrate administration in patients with heart failure. Effect on metabolic responses to submaximal exercise.
Wilson JR; Ferraro N
Am J Med; 1981 Oct; 71(4):627-33. PubMed ID: 7282752
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale.
Rubin LJ; Peter RH
Am J Cardiol; 1981 Jan; 47(1):116-22. PubMed ID: 7457397
[TBL] [Abstract][Full Text] [Related]
14. Short and long-term effects of hydralazine and combined hydralazine and prenalterol therapy in patients with congestive heart failure.
Drexler H; Löllgen H; Just H
Acta Med Scand Suppl; 1982; 659():315-24. PubMed ID: 6127898
[No Abstract] [Full Text] [Related]
15. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
[TBL] [Abstract][Full Text] [Related]
16. Hydralazine in chronic CHF.
Chatterjee K; Rouleau JL; Massie BM
Acta Med Scand Suppl; 1981; 652():99-113. PubMed ID: 6949469
[TBL] [Abstract][Full Text] [Related]
17. Loss of effectiveness of dihydralazine in the long-term treatment of chronic heart failure.
Reifart N; Kaltenbach M; Bussmann WD
Eur Heart J; 1984 Jul; 5(7):568-80. PubMed ID: 6479183
[TBL] [Abstract][Full Text] [Related]
18. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
Pierpont GL; Cohn JN; Franciosa JA
Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
[No Abstract] [Full Text] [Related]
19. Arterial oxygenation and arterial oxygen transport in chronic myocardial failure at rest, during exercise and after hydralazine treatment.
Rubin SA; Brown HV; Swan HJ
Circulation; 1982 Jul; 66(1):143-8. PubMed ID: 7083500
[TBL] [Abstract][Full Text] [Related]
20. Non-parenteral combined afterload and preload reduction therapy in congestive heart failure.
Mehta J; Pepine CJ; Conti CR
Clin Cardiol; 1978 Aug; 1(2):68-73. PubMed ID: 116791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
